Clinical trial sometime in 2022 ???That's a huge timeline and only if they can somehow magically produce protective antibodies.....of which the Vaxhit platform hasn't as of yet as evidenced by the failed USAMRIID experiment......so basically investors have nothing to look forward to till sometime in 2022 ..... Phizer and Moderna are already working on booster shots for the variant mutations and will control this market moving forward.....too much cash at stake